CO2 Inhalation as a New Treatment Modality for Apnea of Prematurity
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The objective of the present proposed study is to discover whether, in the nursery setting,
administration of low concentration inhaled CO2 (0.8%) for a prolonged period (3 days) can
make breathing more regular with less apneic time than that observed with administration of
theophylline. The hypothesis to be tested is that inhalation of low concentration CO2 (0.8%)
will reduce apnea more effectively and will have fewer adverse side effects than
theophylline.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Manitoba
Collaborators:
Canadian Institutes of Health Research (CIHR) The Children's Hospital Foundation of Manitoba